Federal Register / Vol. 74, No. 50 / Tuesday, March 17, 2009 / Notices 11377 

Agenda: On April 1, 2009, the 

committee will hear updates on the 

following topics: National Biovigilance 

Data Collection and Analysis Program; a 

summary of the December 16 and 17, 

2008, meeting of the Department of 

Health and Human Services Advisory 

Committee on Blood Safety and 

Availability; and a summary of the 

September 12, 2008, FDA Workshop on 

Approaches to Minimize the Risk of 

Transfusion-Transmitted Babesiosis in 

the United States. The committee will 

then discuss blood donor screening and 

testing donors of human cells, tissues 

and cellular and tissue-based products 

(HCT/Ps) for hepatitis B virus infection 

by nucleic acid testing. In the afternoon, 

the committee will discuss potential 

testing strategies for Trypanosoma cruzi 

infection in blood donors. On April 2, 

2009, the committee will discuss FDA’s 

current considerations on plasma 

obtained from a Whole Blood donor for 

further manufacturing use and in the 

afternoon will review the research 

programs in the Laboratory of Molecular 

Virology, Division of Emerging and 

Transfusion Transmitted Diseases, 

CBER Site Visit held on October 22, 

2008. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/ohrms/ 

dockets/ac/acmenu.htm, click on the 

year 2009 and scroll down to the 

appropriate advisory committee link. 

Procedure: On April 1, 2009, from 8 

a.m. to 6 p.m. and on April 2, 2009, 

from 8 a.m. to 3:45 p.m, the meeting is 

open to the public. Interested persons 

may present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before March 25, 2009. 

Oral presentations from the public will 

be scheduled between approximately 

11:30 a.m. and 12 noon and between 

approximately 4:15 p.m. and 4:45 p.m. 

on April 1, 2009, and between 

approximately 10:45 a.m. and 11:45 a.m. 

and between approximately 3:15 p.m. 

and 3:45 p.m. on April 2, 2009. Those 

desiring to make formal oral 

presentations should notify the contact 

person and submit a brief statement of 

the general nature of the evidence or 

arguments they wish to present, the 

names and addresses of proposed 

participants, and an indication of the 

approximate time requested to make 

their presentation on or before March 

23, 2009. Time allotted for each 

presentation may be limited. If the 

number of registrants requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

open public hearing session, FDA may 

conduct a lottery to determine the 

speakers for the scheduled open public 

hearing session. The contact person will 

notify interested persons regarding their 

request to speak by March 24, 2009. 

Closed Committee Deliberations: On 

April 2, 2009, between 4 p.m. and 4:45 

p.m., the meeting will be closed to 

permit discussion where disclosure 

would constitute a clearly unwarranted 

invasion of personal privacy (5 U.S.C. 

552b(c)(6)). The committee will discuss 

reports of intramural research programs 

and make recommendations regarding 

personnel staffing decisions. 

Persons attending FDA’s advisory 

committee meetings are advised that the 

agency is not responsible for providing 

access to electrical outlets. 

FDA welcomes the attendance of the 

public at its advisory committee 

meetings and will make every effort to 

accommodate persons with physical 

disabilities or special needs. If you 

require special accommodations due to 

a disability, please contact William 

Freas or Pearline K. Muckelvene at least 

7 days in advance of the meeting. 

FDA is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our Web site at 

http://www.fda.gov/oc/advisory/ 

default.htm for procedures on public 

conduct during advisory committee 

meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: March 10, 2009. 

Randall W. Lutter, 

Deputy Commissioner for Policy. 

[FR Doc. E9–5734 Filed 3–16–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF STATE 

[Public Notice 6545] 

DEPARTMENT OF HOMELAND 

SECURITY 

Certification Related to Implementation 

of The Western Hemisphere Travel 

Initiative 

Pursuant to the authorities vested in 

the Secretary of State and the Secretary 

of Homeland Security, including under 

section 7209(b)(1)(B) of the Intelligence 

Reform and Terrorism Prevention Act of 

2004 (Pub. L. 108–458), as amended by 

section 546 of the Department of 

Homeland Security Appropriations Act, 

2007 (Pub. L. 109–295), section 723 of 

the Implementing Recommendations of 

the 9/11 Commission Act of 2007 (Pub. 

L. 110–53), and section 545 of title V of 

Div. E of the Consolidated 

Appropriations Act of 2008 (Pub. L. 

110–161), we hereby certify that 

(i) The National Institute of Standards 

and Technology certifies that the 

Departments of Homeland Security and 

State have selected a card architecture 

that meets or exceeds International 

Organization for Standardization (ISO) 

security standards and meets or exceeds 

best available practices for protection of 

personal identification documents: That 

the National Institute of Standards and 

Technology has also assisted the 

Departments of Homeland Security and 

State to incorporate into the architecture 

of the card the best available practices 

to prevent the unauthorized use of 

information on the card: That to 

facilitate efficient cross-border travel, 

the Departments of Homeland Security 

and State have, to the maximum extent 

possible, developed an architecture that 

is compatible with information 

technology systems and infrastructure 

used by United States Customs and 

Border Protection; 

(ii) The technology to be used by the 

United States for the passport card, and 

any subsequent change to that 

technology, has been shared with the 

governments of Canada and Mexico; 

(iii) An agreement has been reached 

with the United States Postal Service on 

the fee to be charged individuals for the 

passport card, and a detailed 

justification has been submitted to the 

Committees on Appropriations of the 

Senate and the House of 

Representatives; 

(iv) An alternative procedure has been 

developed for groups of children 

traveling across an international border 

under adult supervision with parental 

consent; 

(v) The necessary technological 

infrastructure to process the passport 

cards has been installed, and all 

employees at ports of entry have been 

properly trained in the use of the new 

technology; 

(vi) The passport card has been made 

available for the purpose of 

international travel by United States 

citizens through land and sea ports of 

entry between the United States and 

Canada, Mexico, the Caribbean and 

Bermuda; 

(vii) A single implementation date for 

sea and land borders has been 

established; and 


dwashington3 on PROD1PC60 with NOTICES
11378 Federal Register / Vol. 74, No. 50 / Tuesday, March 17, 2009 / Notices 

1The record is defined in section 207.2(f) of the 

Commission’s Rules of Practice and Procedure (19 

CFR 207.2(f)). 

2United Steel, Paper and Forestry, Rubber, 

Manufacturing Energy, Allied Industrial and 

Service Workers International Union. 

(viii) The signing of a memorandum 

of agreement to initiate a pilot program 

with not less than one State to 

determine if an enhanced driver’s 

license, which is machine-readable and 

tamper proof, not valid for certification 

of citizenship for any purpose other 

than admission into the United States 

from Canada or Mexico, and issued by 

such State to an individual, may permit 

the individual to use the driver’s license 

to meet the documentation requirements 

under subparagraph (A) of section 

7209(b)(1) for entry into the United 

States from Canada or Mexico at land 

and sea ports of entry. 

This certification and related 

Memorandum of Justification shall be 

provided to the Committees on 

Appropriations of the Senate and House 

of Representatives. This certification 

shall be published in the Federal 

Register. 

Dated: February 24, 2009. 

Janet Napolitano, 

Secretary of Homeland Security. 

Dated: February 24, 2009. 

Hillary Rodham Clinton, 

Secretary of State. 

[FR Doc. E9–5742 Filed 3–16–09; 8:45 am] 

BILLING CODE 4710–06–P 

INTERNATIONAL TRADE 

COMMISSION 

[ Inv. No. 337–TA–660] 

In the Matter of Certain Active Comfort 

Footwear; Notice of Commission 

Determination Not To Review an Initial 

Determination Granting In Part 

Complainants’ Amended Motion To 

Amend the Complaint and Notice of 

Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission has determined not to 

review an initial determination (‘‘ID’’) 

(Order No. 4) of the presiding 

administrative law judge (‘‘ALJ’’) 

granting in part an amended motion to 

amend the complaint and notice of 

investigation. 

FOR FURTHER INFORMATION: Mark B. Rees, 

Esq., Office of the General Counsel, U.S. 

International Trade Commission, 500 E 

Street, SW., Washington, DC 20436, 

telephone 202–205–3116. Copies of the 

ID and all other nonconfidential 

documents filed in connection with this 

investigation are or will be available for 

inspection during official business 

hours (8:45 a.m. to 5:15 p.m.) in the 

Office of the Secretary, U.S. 

International Trade Commission, 500 E 

Street, SW., Washington, DC 20436, 

telephone 202–205–2000. Hearingimpaired persons are advised that 

information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on 202– 

205–1810. General information 

concerning the Commission may also be 

obtained by accessing its Internet server 

(http://www.usitc.gov). The public 

record for this investigation may be 

viewed on the Commission’s electronic 

docket (EDIS) at http://edis.usitc.gov. 

SUPPLEMENTARY INFORMATION: The 

Commission instituted this investigation 

on November 25, 2008, based on the 

complaint of Masai Marketing & Trading 

AG of Romanshorn, Switzerland and 

Masai USA Corp. of Haley, Idaho 

(‘‘Complainants’’). 73 FR 73884 (Nov. 

25, 2008). The complaint, as 

supplemented, alleges violations of 

section 337 of the Tariff Act of 1930 (19 

U.S.C. 1337) in the importation into the 

United States, the sale for importation, 

and the sale within the United States 

after importation of certain active 

comfort footwear that infringes certain 

claims of U.S. Patent No. 6,341,432. 

Complainants named as respondents 

RYN Korea Co., Ltd. of Seoul, Korea; 

Main d/b/a WalkingShoesPlus.com of 

Los Angeles, California; and Feet First 

Inc. of Boca Raton, Florida. 

On January 30, 2009, Complainants filed a 

motion seeking leave to amend the complaint 

and notice of investigation to add three 

additional respondents to the investigation. 

On February 11, 2009, the ALJ issued an ID 

(Order No. 4) in which he determined to 

grant the motion in part and amend the 

notice of investigation to add as respondents 

The Tannery of Cambridge, Massachusetts 

and A Better Way to Health of West 

Melbourne, Florida. No party petitioned for 

review of the ID. 

The Commission has determined not to 

review the ID. 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended (19 U.S.C. 1337), and in 

section 210.42(h) of the Commission’s 

Rules of Practice and Procedure (19 CFR 

210.42(h)). 

By order of the Commission. 

Issued: March 11, 2009. 

Marilyn R. Abbott, 

Secretary to the Commission. 

[FR Doc. E9–5670 Filed 3–16–09; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation Nos. 701–TA–454 and 731– 

TA–1144 (Final)] 

Welded Stainless Steel Pressure Pipe 

From China 

Determination 

On the basis of the record 1 developed 

in the subject investigations, the United 

States International Trade Commission 

(Commission) determines, pursuant to 

section 705(b) and 735(b) of the Tariff 

Act of 1930 (19 U.S.C. 1671d(b) and 

1673d(b)) (the Act), that an industry in 

the United States is materially injured 

by reason of imports from China of 

welded stainless steel pressure pipe, 

provided for in subheadings 7306.40.50 

and 7306.40.10 of the Harmonized Tariff 

Schedule of the United States, that have 

been found by the Department of 

Commerce (Commerce) to be subsidized 

by the Government of China and sold in 

the United States at less than fair value 

(LTFV). 

Background 

The Commission instituted these 

investigations effective January 30, 

2008, following receipt of a petition 

filed with the Commission and 

Commerce by Bristol Metals (Bristol, 

TN), Felker Brothers Corp. (Marshfield, 

WI), Marcegaglia USA, Inc. (Munhall, 

PA), Outokumpu Stainless Pipe, Inc. 

(Schaumburg, IL), and The United Steel 

Workers (Pittsburgh, PA).2 The final 

phase of the investigations was 

scheduled by the Commission following 

notification of preliminary 

determinations by Commerce that 

imports of welded stainless steel 

pressure pipe from China were being 

subsidized by the Government of China 

and being sold at LTFV within the 

meaning of section 703(b) and 733(b) of 

the Act (19 U.S.C. 1671b(b) and 

1673b(b)). Notice of the scheduling of 

the final phase of the Commission’s 

investigations and of a public hearing to 

be held in connection therewith was 

given by posting copies of the notice in 

the Office of the Secretary, U.S. 

International Trade Commission, 

Washington, DC, and by publishing the 

notice in the Federal Register of 

October 6, 2008 (73 FR 58265). The 

hearing was held in Washington, DC, on 

January 13, 2009, and all persons who 

requested the opportunity were 


dwashington3 on PROD1PC60 with NOTICES